b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Data-Review" Owner="NLM">\n        <PMID Version="1">31325332</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>07</Month>\n            <Day>01</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1469-0705</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>55</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Mar</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology</Title>\n                <ISOAbbreviation>Ultrasound Obstet Gynecol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Development and validation of predictive models for QUiPP App v.2: tool for predicting preterm birth in asymptomatic high-risk women.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>348-356</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/uog.20401</ELocationID>\n            <Abstract>\n                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Accurate mid-pregnancy prediction of spontaneous preterm birth (sPTB) is essential to ensure appropriate surveillance of high-risk women. Advancing the QUiPP App prototype, QUiPP App v.2 aimed to provide individualized risk of delivery based on cervical length (CL), quantitative fetal fibronectin (qfFN) or both tests combined, taking into account further risk factors, such as multiple pregnancy. Here we report development of the QUiPP App v.2 predictive models for use in asymptomatic high-risk women, and validation using a distinct dataset in order to confirm the accuracy and transportability of the QUiPP App, overall and within specific clinically relevant time frames.</AbstractText>\n                <AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective secondary analysis of data of asymptomatic women at high risk of sPTB recruited in 13 UK preterm birth clinics. Women were offered longitudinal qfFN testing every 2-4\xe2\x80\x89weeks and/or transvaginal ultrasound CL measurement between 18\xe2\x80\x89+\xe2\x80\x890 and 36\xe2\x80\x89+\xe2\x80\x896\xe2\x80\x89weeks\' gestation. A total of 1803 women (3878 visits) were included in the training set and 904 women (1400 visits) in the validation set. Prediction models were created based on the training set for use in three groups: patients with risk factors for sPTB and CL measurement alone, with risk factors for sPTB and qfFN measurement alone, and those with risk factors for sPTB and both CL and qfFN measurements. Survival analysis was used to identify the significant predictors of sPTB, and parametric structures for survival models were compared and the best selected. The estimated overall probability of delivery before six clinically important time points (&lt;\xe2\x80\x8930, &lt;\xe2\x80\x8934 and &lt;\xe2\x80\x8937\xe2\x80\x89weeks\' gestation and within 1, 2 and 4\xe2\x80\x89weeks after testing) was calculated for each woman and analyzed as a predictive test for the actual occurrence of each event. This allowed receiver-operating-characteristics curves to be plotted, and areas under the curve (AUC) to be calculated. Calibration was performed to measure the agreement between expected and observed outcomes.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">All three algorithms demonstrated high accuracy for the prediction of sPTB at &lt;\xe2\x80\x8930, &lt;\xe2\x80\x8934 and &lt;\xe2\x80\x8937\xe2\x80\x89weeks\' gestation and within 1, 2 and 4\xe2\x80\x89weeks of testing, with AUCs between 0.75 and 0.90 for the use of qfFN and CL combined, between 0.68 and 0.90 for qfFN alone, and between 0.71 and 0.87 for CL alone. The differences between the three algorithms were not statistically significant. Calibration confirmed no significant differences between expected and observed rates of sPTB within 4\xe2\x80\x89weeks and a slight overestimation of risk with the use of CL measurement between 22\xe2\x80\x89+\xe2\x80\x890 and 25\xe2\x80\x89+\xe2\x80\x896\xe2\x80\x89weeks\' gestation.</AbstractText>\n                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The QUiPP App v.2 is a highly accurate prediction tool for sPTB that is based on a unique combination of biomarkers, symptoms and statistical algorithms. It can be used reliably in the context of communicating to patients the risk of sPTB. Whilst further work is required to determine its role in identifying women requiring prophylactic interventions, it is a reliable and convenient screening tool for planning follow-up or hospitalization for high-risk women. Copyright \xc2\xa9 2019 ISUOG. Published by John Wiley &amp; Sons Ltd.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 ISUOG. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Watson</LastName>\n                    <ForeName>H A</ForeName>\n                    <Initials>HA</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0002-6332-1907</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Women and Children\'s Health, School of Life Course Sciences, King\'s College London, London, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Seed</LastName>\n                    <ForeName>P T</ForeName>\n                    <Initials>PT</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Women and Children\'s Health, School of Life Course Sciences, King\'s College London, London, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Carter</LastName>\n                    <ForeName>J</ForeName>\n                    <Initials>J</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0003-2550-6465</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Women and Children\'s Health, School of Life Course Sciences, King\'s College London, London, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hezelgrave</LastName>\n                    <ForeName>N L</ForeName>\n                    <Initials>NL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Women and Children\'s Health, School of Life Course Sciences, King\'s College London, London, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kuhrt</LastName>\n                    <ForeName>K</ForeName>\n                    <Initials>K</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0001-5016-0430</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Women and Children\'s Health, School of Life Course Sciences, King\'s College London, London, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tribe</LastName>\n                    <ForeName>R M</ForeName>\n                    <Initials>RM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Women and Children\'s Health, School of Life Course Sciences, King\'s College London, London, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Shennan</LastName>\n                    <ForeName>A H</ForeName>\n                    <Initials>AH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Women and Children\'s Health, School of Life Course Sciences, King\'s College London, London, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>CDRF-2013-04-026</GrantID>\n                    <Agency>National Institute for Health Research (NIHR) Biomedical Research Centre</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>298582</GrantID>\n                    <Agency>Rose-tree Trust</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>1060508</GrantID>\n                    <Agency>Tommy\'s Charity</Agency>\n                    <Country/>\n                </Grant>\n                <Grant>\n                    <GrantID>DRF-2013-06-171</GrantID>\n                    <Acronym>DH_</Acronym>\n                    <Agency>Department of Health</Agency>\n                    <Country>United Kingdom</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>CDRF-2013-04-026</GrantID>\n                    <Acronym>DH_</Acronym>\n                    <Agency>Department of Health</Agency>\n                    <Country>United Kingdom</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>DRF-2013-06-171</GrantID>\n                    <Agency>National Institute for Health Research (NIHR) Biomedical Research Centre</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Ultrasound Obstet Gynecol</MedlineTA>\n            <NlmUniqueID>9108340</NlmUniqueID>\n            <ISSNLinking>0960-7692</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">App</Keyword>\n            <Keyword MajorTopicYN="N">cervical length</Keyword>\n            <Keyword MajorTopicYN="N">fetal fibronectin</Keyword>\n            <Keyword MajorTopicYN="N">preterm birth</Keyword>\n            <Keyword MajorTopicYN="N">risk assessment</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>04</Month>\n                <Day>18</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>20</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>05</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>22</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>22</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>7</Month>\n                <Day>21</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31325332</ArticleId>\n            <ArticleId IdType="doi">10.1002/uog.20401</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Title>REFERENCES</Title>\n            <Reference>\n                <Citation>NHS England. Saving Babies\' Lives Version Two: A care bundle for reducing perinatal mortality. 2019. https://www.england.nhs.uk/publication/saving-babies-lives-version-two-a-care-bundle-for-reducing-perinatal-mortality/.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>National Institute for Health and Care Excellence (NICE). Preterm Labour and Birth. NICE guideline NG25.\xc2\xa0NICE: London, 2015. https://www.nice.org.uk/guidance/ng25.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Abbott DS, Hezelgrave NL, Seed PT, Norman JE, David AL, Bennett PR, Girling JC, Chandirimani M, Stock SJ, Carter J, Kurtzman J, Tribe RM, Shennan AH. Quantitative fetal fibronectin to predict preterm birth in asymptomatic women at high risk. Obstet Gynecol 2015; 125: 1168-1175.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ridout A, Carter J, Shennan A. Clinical utility of quantitative fetal fibronectin in preterm labour. BJOG 2016; 123: 1972.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kuhrt K, Smout E, Hezelgrave N, Seed PT, Carter J, Shennan AH. Development and validation of a tool incorporating cervical length and quantitative fetal fibronectin to predict spontaneous preterm birth in asymptomatic high-risk women. Ultrasound Obstet Gynecol 2016; 47: 104-109.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Carter J, Tribe RM, Shennan AH, Sandall J. Threatened preterm labour: Women\'s experiences of risk and care management: A qualitative study. Midwifery 2018; 64: 85-92.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Watson HA, Ridout A, Ross G, Shennan AH. Decision-making about preterm birth using the QUIPP app: A survey of women\'s experiences. Pregnancy Outcome Poster Abstracts P.PO.33. BJOG 2017; 124(S2): doi:10.1111/1471-0528.14589.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Office of National Statistics. Birth characteristics in England and Wales. 2015. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/livebirths/bulletins/birthcharacteristicsinenglandandwales/2015.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Carter J, Seed PT, Watson HA, David AL, Sandall J, Shennan AH, Tribe RM. Development and validation of prediction models for QUiPP App v.2: tool for predicting preterm birth in women with symptoms of threatened preterm labor. Ultrasound Obstet Gynecol 2020; 55: 357-367.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Altman DG, Royston P. What do we mean by validating a prognistic model? Stat Med 2000; 19: 453-473.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med 1999; 130: 515-524.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Bolt LA, Chandiramani M, De Greeff A, Seed PT, Kurtzman J, Shennan AH. The value of combined cervical length measurement and fetal fibronectin testing to predict spontaneous preterm birth in asymptomatic high-risk women. J Matern Neonatal Med 2011; 24: 928-932.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Hezelgrave NL, Watson HA, Ridout A, Diab F, Seed PT, Chin-Smith E, Tribe RM, Shennan AH. Rationale and design of SuPPoRT: A multi-centre randomised controlled trial to compare three treatments: Cervical cerclage, cervical pessary and vaginal progesterone, for the prevention of preterm birth in women who develop a short cervix. BMC Pregnancy Childbirth 2016; 16: 358.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Norman JE, Norrie J, Maclennan G, Cooper D, Whyte S, Burley SC, Smith JBE, Shennan A, Robson SC, Thornton S, Kilby MD, MArlow N, Stock SJ, Bennett PR, Denton J. Open randomised trial of the (Arabin) pessary to prevent preterm birth in twin pregnancy with health economics and acceptability: STOPPIT-2-a study protocol. BMJ Open 2018; 8: e026430.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Carpenter J, Bithell J. Bootstrap confidence intervals: When, which, what? A practical guide for medical statisticians. Stat Med 2000; 19: 1141-1164.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models: A framework for traditional and novel measures. Epidemiology 2010; 21: 128-138.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, CAlder A, Mires G, Danielian P, Sturgiss S, MacLennan G, Tydeman G, Thornton S, MArton B, Thornton JG, Neilson JP, Norrie J. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 2009; 373: 2034-2040.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Nicolaides KH, Syngelaki A, Poon LC, de Paco Matallana C, Plasencia W, Molina FS, Picciarelli G, Tul N, Celik E, Lau TK, Conturso R. Cervical pessary placement for prevention of preterm birth in unselected twin pregnancies: a randomized controlled trial. Am J Obstet Gynecol 2015; 214: 3.e1-9.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 2005; 106: 181-189.</Citation>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'